NCT05594095 2024-10-04SNF Platform Study of HR+/ HER2-advanced Breast CancerFudan UniversityPhase 2 Recruiting620 enrolled
NCT05891093 2024-02-08Efficacy and Safety of Fluzoparib Combined With Adjuvant Endocrine Therapy for HR+/HER2- SNF3-subtype Early Breast Cancer (BCTOP-L-A01)Fudan UniversityPhase 3 Recruiting766 enrolled